Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Annual profits miss targets at BASF

(Sharecast News) - German chemical giant BASF Group reported annual sales and earnings well below analyst expectations on Friday. Releasing preliminary figures for 2023, BASF said annual sales were €68.9bn, below both internal and external forecasts for €73bn to €76bn. Sales in 2022 were €87.3bn.

Expected income from operations before special items fell from €6.9bn to €3.8bn, less than the €4bn to €4.4bn expected. BASF said the decrease was due to "sales-related lower margins, which could not be offset by the achieved fixed cost reduction".

Net income, however, was €225m, a notable improvement on 2022's net loss of €627m, when the firm was hit by non-cash impairments relating to its exit from Russia.

BASF's energy intensive operations have left it grappling with higher costs and falling earnings. Demand has also softened.

Last year it launched a major cost cutting programme, and in December announced that Markus Kamieth would take over as chief executive from outgoing incumbent Martin Brudermuller in April.

Kamieth currently oversees BASF's China operations, a key market for the company.

BASF, the world's largest chemicals company, will publish final full-year figures on 23 February.

Share this article

Related Sharecast Articles

Yellow Cake NAV slips as uranium values decline
(Sharecast News) - Uranium investor Yellow Cake reported a rise in uranium holdings but a decrease in net asset value due to lower spot prices in its interim results on Tuesday.
Digitalbox FY EBITDA now seen ahead of internal expectations
(Sharecast News) - Digital media business Digtalbox said on Tuesday that it now expects FY24 revenues to be at least £3.5m, while underlying earnings were also seen ahead of management's expectations.
Dianomi expects to record small loss in FY24
(Sharecast News) - Digital advertising business Dianomi warned on Tuesday that it and to record a small loss in FY24 compared to market expectations of a small profit.
Ixico secures new contract with US-based client
(Sharecast News) - Neuroscience imaging firm Ixico has signed a contract with a new US-based client to provide imaging services for a Phase 2 Huntington's Disease clinical trial.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.